Silk Road Medical, Inc. Common Stock
SILK
SILK was delisted on the 16th of September, 2024.
185 hedge funds and large institutions have $2.21B invested in Silk Road Medical, Inc. Common Stock in 2020 Q4 according to their latest regulatory filings, with 36 funds opening new positions, 67 increasing their positions, 61 reducing their positions, and 17 closing their positions.
25,884% more call options, than puts
Call options by funds: $8.05M | Put options by funds: $31K
112% more first-time investments, than exits
New positions opened: 36 | Existing positions closed: 17
11% more funds holding
Funds holding: 166 → 185 (+19)
10% more repeat investments, than reductions
Existing positions increased: 67 | Existing positions reduced: 61
5% less capital invested
Capital invested by funds: $2.32B → $2.21B (-$109M)
100% less funds holding in top 10
Funds holding in top 10: 2 → 0 (-2)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BlackRock
New York
|
+$30.3M |
| 2 |
Marshall Wace
London,
United Kingdom
|
+$29.1M |
| 3 |
FAM
Fred Alger Management
New York
|
+$8.16M |
| 4 |
ClearBridge Investments
New York
|
+$7.2M |
| 5 |
DM
Deerfield Management
New York
|
+$7.01M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Lord, Abbett & Co
Jersey City,
New Jersey
|
-$54.7M |
| 2 |
Invesco
Atlanta,
Georgia
|
-$16.6M |
| 3 |
Jennison Associates
New York
|
-$8.1M |
| 4 |
TCM
Tygh Capital Management
Portland,
Oregon
|
-$5.41M |
| 5 |
Federated Hermes
Pittsburgh,
Pennsylvania
|
-$4.3M |
SILK Hedge Fund Activity: Q4 2020 in Review
185 of the 5,652 institutional investors tracked by Wall St. Rank reported a position in Silk Road Medical, Inc. Common Stock (SILK) for Q4 2020, worth a combined $2.21B — down 4.7% from $2.32B a quarter earlier.
Buyers outnumbered sellers: 36 funds opened new SILK positions and 17 closed out — a net gain of 19 holders — while 67 added to existing stakes and 61 trimmed.
The largest buyer was BlackRock, adding an estimated $30.3M. The largest seller was Lord, Abbett & Co, cutting an estimated $54.7M.
- 185 institutional investors held Silk Road Medical, Inc. Common Stock (SILK) as of Q4 2020, up from 166 in Q3 2020.
- Funds reported $2.21B of Silk Road Medical, Inc. Common Stock stock for Q4 2020, down 4.7% quarter-over-quarter.
- 36 funds opened new Silk Road Medical, Inc. Common Stock positions in Q4 2020 and 17 closed out, a net change of +19 holders.
- The largest Silk Road Medical, Inc. Common Stock buyer in Q4 2020 was BlackRock, an estimated $30.3M added.
- The largest Silk Road Medical, Inc. Common Stock seller in Q4 2020 was Lord, Abbett & Co, an estimated $54.7M sold.
Based on aggregated 13F filings for Q4 2020.